American Society of Hematology

Figure 4.

$Figure 4. Survival by disease status at study entry. Deaths were related to relapse in patient nos. 7, 6, and 1 (one de novo after allogeneic SCT, one CR at start after change in therapy, one primary refractory while on therapy) or other causes while in CR for one de novo and one primary refractory (patient nos. 14, 13).$

Survival by disease status at study entry. Deaths were related to relapse in patient nos. 7, 6, and 1 (one de novo after allogeneic SCT, one CR at start after change in therapy, one primary refractory while on therapy) or other causes while in CR for one de novo and one primary refractory (patient nos. 14, 13).

This Feature Is Available To Subscribers Only